tiprankstipranks
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market
APLLTD
Alembic Pharmaceuticals Limited
RESEARCH TOOLSreports

Alembic Pharmaceuticals Limited (APLLTD) Ratios

2 Followers

Alembic Pharmaceuticals Limited Ratios

IN:APLLTD's free cash flow for Q2 2026 was ₹0.46. For the 2026 fiscal year, IN:APLLTD's free cash flow was decreased by ₹ and operating cash flow was ₹0.13. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.59 1.69 2.12 1.78 1.67
Quick Ratio
 0.66 0.75 0.99 0.88 0.73
Cash Ratio
 0.05 0.04 0.08 0.05 0.04
Solvency Ratio
 0.30 0.33 0.53 0.33 0.42
Operating Cash Flow Ratio
 0.15 0.04 0.55 0.44 0.32
Short-Term Operating Cash Flow Coverage
 0.29 0.07 1.87 1.14 0.88
Net Current Asset Value
₹ 12.69B₹ 15.04B₹ 14.51B₹ 10.98B₹ 9.76B
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.16 0.08 0.12 0.10
Debt-to-Equity Ratio
 0.28 0.24 0.11 0.17 0.14
Debt-to-Capital Ratio
 0.22 0.20 0.10 0.14 0.12
Long-Term Debt-to-Capital Ratio
 <0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.58 1.50 1.34 1.41 1.36
Debt Service Coverage Ratio
 0.66 0.68 1.85 1.00 1.16
Interest Coverage Ratio
 16.37 34.30 44.64 39.48 103.26
Debt to Market Cap
 0.11 0.07 0.02 0.07 0.04
Interest Debt Per Share
 80.60 67.98 28.97 39.28 37.38
Net Debt to EBITDA
 1.19 1.18 0.43 0.93 0.76
Profitability Margins
Gross Profit Margin
57.38%71.81%71.16%68.60%71.76%
EBIT Margin
11.61%10.94%10.61%7.74%11.07%
EBITDA Margin
15.55%14.82%14.68%12.32%16.18%
Operating Profit Margin
21.53%40.49%40.27%35.04%34.51%
Pretax Profit Margin
10.56%10.60%10.14%6.27%11.79%
Net Profit Margin
8.66%8.74%9.89%6.05%9.82%
Continuous Operations Profit Margin
8.61%8.72%9.89%6.05%9.82%
Net Income Per EBT
81.97%82.50%97.47%96.44%83.30%
EBT Per EBIT
49.05%26.17%25.19%17.90%34.16%
Return on Assets (ROA)
7.49%7.51%9.55%5.53%7.31%
Return on Equity (ROE)
12.22%11.24%12.78%7.83%9.95%
Return on Capital Employed (ROCE)
27.61%50.40%50.26%43.57%33.87%
Return on Invested Capital (ROIC)
18.05%33.84%44.94%36.74%25.21%
Return on Tangible Assets
7.69%7.51%9.55%5.53%7.48%
Earnings Yield
4.41%3.31%3.11%3.51%3.57%
Efficiency Ratios
Receivables Turnover
 5.53 4.77 6.08 5.38 6.54
Payables Turnover
 3.49 2.14 2.44 2.61 2.12
Inventory Turnover
 1.22 0.82 1.09 1.20 0.93
Fixed Asset Turnover
 2.07 1.99 2.03 1.88 1.34
Asset Turnover
 0.87 0.86 0.97 0.91 0.74
Working Capital Turnover Ratio
 8.97 4.04 4.30 4.68 4.22
Cash Conversion Cycle
 260.87 349.88 244.56 231.48 275.87
Days of Sales Outstanding
 66.00 76.58 60.06 67.89 55.80
Days of Inventory Outstanding
 299.46 444.06 333.99 303.40 392.16
Days of Payables Outstanding
 104.59 170.76 149.49 139.81 172.09
Operating Cycle
 365.46 520.64 394.05 371.29 447.96
Cash Flow Ratios
Operating Cash Flow Per Share
 20.50 4.48 40.86 36.83 28.10
Free Cash Flow Per Share
 8.59 -24.20 24.20 14.27 6.45
CapEx Per Share
 11.91 28.67 16.66 22.56 21.65
Free Cash Flow to Operating Cash Flow
 0.42 -5.41 0.59 0.39 0.23
Dividend Paid and CapEx Coverage Ratio
 0.89 0.11 1.66 1.13 0.79
Capital Expenditure Coverage Ratio
 1.72 0.16 2.45 1.63 1.30
Operating Cash Flow Coverage Ratio
 0.27 0.07 1.57 1.00 0.77
Operating Cash Flow to Sales Ratio
 0.06 0.01 0.13 0.13 0.10
Free Cash Flow Yield
1.18%-2.70%2.40%2.88%0.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 21.57 30.22 32.20 28.53 27.98
Price-to-Sales (P/S) Ratio
 1.87 2.64 3.18 1.73 2.75
Price-to-Book (P/B) Ratio
 2.55 3.40 4.12 2.23 2.78
Price-to-Free Cash Flow (P/FCF) Ratio
 80.38 -37.06 41.69 34.78 115.04
Price-to-Operating Cash Flow Ratio
 33.67 200.40 24.69 13.48 26.39
Price-to-Earnings Growth (PEG) Ratio
 -27.81 -5.74 0.40 -0.83 -0.51
Price-to-Fair Value
 2.55 3.40 4.12 2.23 2.78
Enterprise Value Multiple
 13.20 19.00 22.13 14.94 17.74
Enterprise Value
 156.21B 187.96B 202.25B 104.03B 152.33B
EV to EBITDA
 13.83 19.00 22.13 14.94 17.74
EV to Sales
 2.15 2.82 3.25 1.84 2.87
EV to Free Cash Flow
 92.57 -39.52 42.51 37.08 120.22
EV to Operating Cash Flow
 38.77 213.67 25.18 14.37 27.58
Tangible Book Value Per Share
 259.16 264.01 245.12 222.34 258.58
Shareholders’ Equity Per Share
 270.62 264.09 245.12 222.34 266.46
Tax and Other Ratios
Effective Tax Rate
 0.18 0.18 0.03 0.04 0.17
Revenue Per Share
 369.69 339.44 316.88 287.57 269.93
Net Income Per Share
 32.00 29.68 31.33 17.40 26.50
Tax Burden
 0.82 0.82 0.97 0.96 0.83
Interest Burden
 0.91 0.97 0.96 0.81 1.06
Research & Development to Revenue
 0.07 0.08 0.08 0.13 0.16
SG&A to Revenue
 0.29 0.23 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.51 0.15 1.30 2.04 0.89
Currency in INR